ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 2.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $138,000 | -13.8% | 11,075 | -5.4% | 0.00% | 0.0% |
| Q3 2016 | $160,000 | +83.9% | 11,708 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $87,000 | +20.8% | 11,708 | +3.2% | 0.00% | – |
| Q1 2016 | $72,000 | -2.7% | 11,341 | -4.7% | 0.00% | – |
| Q4 2015 | $74,000 | +2.8% | 11,902 | -3.9% | 0.00% | – |
| Q3 2015 | $72,000 | -29.4% | 12,383 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $102,000 | -2.9% | 12,383 | -3.1% | 0.00% | 0.0% |
| Q1 2015 | $105,000 | +19.3% | 12,784 | 0.0% | 0.00% | – |
| Q4 2014 | $88,000 | +22.2% | 12,784 | -3.9% | 0.00% | – |
| Q3 2014 | $72,000 | -15.3% | 13,297 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $85,000 | – | 13,297 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |